JWA, a newly identified novel microtubule-associated protein (MAP), was recently demonstrated to be indispensable for the rearrangement of actin cytoskeleton and activation of MAPK cascades induced by arsenic trioxide (As 2 O 3 ) and phorbol ester (PMA). JWA depletion blocked the inhibitory effect of As 2 O 3 on HeLa cell migration, but enhanced cell migration after PMA treatment. As cancer cell migration is a hallmark of tumor metastasis and the functional role of JWA in cancer metastasis is not understood, here we show that JWA has an important role in melanoma metastasis. Our data demonstrated that JWA knockdown increased the adhesion and invasion abilities of melanoma cells. Furthermore, JWA knockdown in B16-F10 and A375 melanoma cells significantly promoted the formation and growth of metastatic colonies in vivo. Moreover, in the tumor biopsies from human melanoma patients, JWA expression was significantly decreased in malignant melanoma compared with normal nevi. In addition, we found that JWA knockdown could intensify tumor integrin a V b 3 signaling by regulating nuclear factor Sp1. These findings suggest that JWA suppresses melanoma metastasis and may serve a potential therapeutic target for human melanoma.
Introduction
Melanoma is one of the most frequent malignant tumors in younger age population, and is characterized by its high capacity for metastasis. The incidence of human melanoma has drastically increased over the past several decades. In the United States of America, the number of new cases of melanoma in 2008 was estimated to be 62 480 and it was predicted to have 8420 deaths due to melanoma (Jemal et al., 2008) . Although melanoma accounts for only 4% of skin cancer cases, it is the leading cause of skin cancer deaths according to the American Cancer Society (Balch et al., 2001) . The major mortality is due to tumor metastasis; only o5% of patients with metastatic melanoma survive for 5 years (Sampsel and Barbera-Guillem, 2004) .
The prognosis for metastatic melanoma is dismal because this type of cancer often evades established therapeutic regimens (Becker et al., 2000) . Therefore, any insight into the mechanisms of melanoma cell metastasis may contribute to the development of more effective and specific strategies to interfere with melanoma progression. Melanoma cells begin to express the adhesion receptor integrin a V b 3 at the onset of invasive tumor growth in the skin (Moretti et al., 1997) . The receptor strongly supports melanoma tumorigenicity in vivo (Felding-Habermann et al., 1992) and melanoma cell survival and proliferation in vitro (Montgomery et al., 1994) . Integrin a V b 3 further supports adhesive and invasive tumor cell functions that are critical during melanoma progression (Seftor et al., 1999) . Thus, blocking integrin a V b 3 is expected to have a broad theoretical impact in cancer therapy and diagnosis.
The JWA gene was initially cloned from human tracheal bronchial epithelial cells after treatment with all-trans retinoic acid (Zhou et al., 1999) . Several JWA homologues (e.g., ARL-6, GTRAP3-18, addicsin and JM4) were since identified (Butchbach et al., 2002; Schweneker et al., 2005) . These homologues contain a large prenylated Rab acceptor 1 domain, believed to form a new family of ADP-ribosylation factor proteins that has a role in the regulation of intracellular protein transport (Ingley et al., 1999) . There is an increasing amount of data to indicate that JWA is a structurally novel mitogen-activated protein (MAP) (Li et al., 2003; Chen et al., 2004) , not only induced by various agents such as PMA, ATRA or As 2 O 3 , but also possesses functions related to microtubule formation. However, the underlying molecular mechanisms of JWA in the regulation of cell migration remain to be elucidated.
We previously reported that JWA regulates cancer cell migration through MAPK cascades and F-actin cytoskeleton, which suggested that JWA has a potential inhibitory role in cancer metastasis (Chen et al., 2007a) .
In this study, we tested the hypothesis that JWA regulates cell adhesion and melanoma metastasis by inhibiting integrin a V b 3 signaling. Our results demonstrated that JWA significantly inhibits cell adhesion, invasion and the metastasis of B16-F10 and A375 melanoma cells probably through suppressing integrin a V b 3 signaling. These data imply that JWA may be used as a potential therapeutic target for this aggressive malignancy.
Results

JWA knockdown enhances melanoma metastasis in vivo
We previously showed that JWA regulates cancer cell migration through MAPK cascades and F-actin cytoskeleton, suggesting that JWA could have an important role in cancer metastasis (Chen et al., 2007a) . To further address the functional role of JWA in cancer metastasis, B16-F10 and A375, two metastatic melanoma cell lines were selected as our in vivo model. B16-F10 and A375 cells were transfected with either pEGFP-C1 vector or pEGFP-C1-As JWA (antisense). After selection with G418, pools of cells were generated that inhibited JWA expression (B16-As and A375-As) and vector control (B16-Vec and A375-Vec) (Figure 1a) .
To test the suppressive effect of JWA on melanoma metastasis in vivo, mice were injected through tail vein with JWA knockdown and vector control cells. For murine B16 melanoma cell line in vivo metastasis animal model, 21 days after injection, one mouse injected with B16-As cells died, and the other mice were killed to examine the tumor formation in the lungs. Extensive tumor formation was found in B16-As group. In contrast, the lungs from the mice injected with B16-Vec cells showed much fewer and smaller tumor nodules compared with B16-As group (Figure 1b, top panel) . Histological examination of the lung tissue sections from the mice injected with B16-As cells revealed high density of tumor nodules that invaded most of the lung parenchyma. However, the lungs from the mice injected with B16-Vec cells had fewer detectable tumor nodules (Figure 1b , middle panel). Immunohistochemical staining showed that JWA expression in B16-As group is much lower compared with B16-Vec group (Figure 1b, bottom panel) . A statistically significant increase in the number of the lung metastases was seen in mice injected with B16-As cells, compared with the mice injected with B16-Vec cells (Figure 1c) .
For A375 human melanoma cell line in vivo metastasis animal model, 30 days after injection, the metastatic tumors were found in the lymph nodes of the neck of 40% mice in A375-As group, however, no metastatic tumor was found in the lymph nodes of the neck in A375-Vec group (Figure 1d , top and middle panel). According to the pathological results, all the metastatic tumors possess the characteristics of melanoma. For example, melanin, enlarged nuclei and clear nucleolus can be observed, thereby indicating that the metastatic tumors are the results of the growth of A375 cell line (Figure 1d , bottom panel). We also found metastatic tumor nodules in the lung (2/3 mice) and the kidney (1/3 mice) of the A375-As group. But in A375-Vec group, we only found a small tumor nodule in the lung (Supplementary Figure S1) . These in vivo results support our hypothesis that JWA inhibits the metastasis of melanoma cells.
To confirm that the increased number of tumor nodules in JWA knockdown group is due to the promotion of metastasis, not the promotion of cell proliferation by pEGFP-C1-As JWA plasmid, we carried out cell proliferation assay. Our data indicated that the cell proliferation rates were similar between control cells and the JWA knockdown cells (Figure 1e ).
JWA inhibits cell attachment in melanoma cells
Cancer metastatic process consists of a number distinct steps including detachment of tumor cells from the primary site, penetration of tumor cells through the endothelium of blood or lymphatic vessels to enter the circulation, and finally, in the new host environment, adhesion and reinvasion, and proliferation of the tumor cells to form a secondary tumor (Hynes, 2003) . JWA may have important roles in one or more steps to regulate tumor metastasis.
We previously reported that JWA knockdown could promote B16 melanoma cell migration (Chen et al., 2007a) . Here we confirmed this conclusion by using wound healing assay, transwell assay and immunofluorescence analysis. Our data showed that knockdown of JWA significantly promoted cell migration by regulating actin cytoskeleton rearrangements when compared with the cells carrying control vector (Supplementary Figure S2-S4 ). As JWA is involved in actin organization in cancer cells, we tested whether JWA regulated cell attachment on fibronectin and vitronectin coated plates. Cells were allowed to attach to fibronectin and vitronectin coated plates for 1 h. The unattached cells were washed away. Attached cells were stained and quantified by MTT assay. JWA knockdown increased cell attachment ability of melanoma cell in fibronectinand vitronectin-coated plates by 103 and 69%, respectively ( Figure 2a , top panel). To further confirm the result, JWA short hairpin RNA (shRNA) was used to knockdown the JWA protein expression in human melanoma cell line A375. The silencing of JWA in A375 cells also increased cell attachment ability in fibronectin-and vitronectin-coated plates by 75 and 58%, respectively (Figure 2a , bottom panel).
JWA suppresses cell invasion and matrix metalloproteinases (MMPs) activities in melanoma cells
We next investigated the role of JWA in invasion of melanoma cells. We found that cells from B16-As cells and A375-shRNA cells had increased the ability to invade through Matrigel-coated Boyden chamber by 173 and 79%, respectively, compared to the control cells (Figures 2b and c) . Invasive ability of cancer cells can be regulated by MMPs. We performed zymography to measure the MMPs activities in melanoma cells. Our results showed that there was no significant difference in MMP-9 activity between B16-As cells and B16-vector cells, but MMP-2 activity was dramatically increased in B16-As cells by 4.5-fold ( Figure 2d ).
Integrin a V b 3 signaling intensifies after JWA knockdown To elucidate the molecular mechanism involved in the increased metastasis of melanoma cells after JWA knockdown, we focused on the regulation of JWA on integrin a V b 3 for the following reasons: (1) integrin a V b 3 is a well-known key factor for tumor metastasis; (2) integrin a V b 3 is upregulated in melanoma; and (3) fibronectin and vitronectin are ligands for a V b 3 (Albelda et al., 1990; Gladson and Cheresh, 1991; Nip and Brodt, 1995; Horton, 1997) . Therefore, we hypothesized that JWA may inhibit melanoma metastasis by suppressing integrin a V b 3 signaling. To test this hypothesis, we first determined the mRNA levels of integrin a V and b 3 subunits in B16 cells after JWA knockdown. RT-PCR results showed that the levels of integrin a V and b 3 mRNA were increased 1.9-fold and 2.4-fold in B16-As cells, respectively. In contrast, JWA mRNA expression was knocked down by 60% in B16-As cells (Figure 3a) . We then conducted western blot analysis to measure the protein levels of integrin a V and b 3 subunits, and the focal adhesion kinase (FAK) and its phosphorylation status, a critical mediator of integrin signaling (Mitra and Schlaepfer, 2006 ; van Nimwegen and van de Water, 2007). We also detected the expression of p21-activated kinase (PAK)-1 and its phosphorylation status, a downstream molecule of integrin a V b 3 signaling pathway (Zhou and Kramer, 2005; Cheng et al., 2009) . Our results showed that the knockdown of JWA upregulated FAK and PAK-1 expression and activated their phosphorylation status in both B16 cells (Figure 3b , left panel) and A375 cells (Figure 3b, right panel) .
To further confirm whether JWA was essential for the expression of integrin a V b 3 signaling, we designed JWA rescue cell culture models. JWA knockdown B16 cells were transiently transfected with pEGFP-C1-JWA to produce JWA-rescued B16 cells, which recovered JWA expression. The integrin a V b 3 signaling was completely recovered in the cells of rescued JWA expression (Figure 3b, middle panel) . In addition, JWA-rescued B16 cells returned its ability in cell adhesion and invasion to a level comparable to the vector-control B16 cells (Figures 3c and d ).
Targeting integrin a V b 3 signaling reduced cell adhesion and invasion of melanoma cells after JWA knockdown The above data revealed a potential role of integrin a V b 3 to increased melanoma metastasis after JWA knockdown. To verify this, RNA interference using short siRNA was used to silence the expression of integrin a V and b 3 in JWA knockdown cells. Incubation with 10 nmol/l integrin a V or b 3 siRNA induced a timedependent suppression of protein expression. Seventytwo hours after transfection, the expressions of a V and b 3 were almost completely silenced (Supplementary Figure  S5) . We then used a V b 3 siRNA and LM609, an antiintegrin a V b 3 monoclonal antibody, to knockdown or block a V b 3 expression. Our results showed that both integrin a V b 3 and its downstream molecules FAK and PAK1 were downregulated (Figure 4a ). After the knockdown of integrin a V b 3 in B16-As and A375-sh cells, the ability of adhesion and invasion of JWA knockdown cells were both drastically decreased (Figures 4b-e) .
It has been reported that transcription factors AP-1, Ets-1 and Sp1 bind to integrin a V and b 3 promoter regions and regulate integrin a V and b 3 transcription (Tajima et al., 2000; Rothhammer et al., 2004; Pechkovsky et al., 2008; Lossner et al., 2009) . To address how JWA knockdown upregulates integrin a V b 3 , RT-PCR was used to determine the mRNA levels of these transcription factors after JWA knockdown. In B16-As cells, the mRNA levels of Ets-1 and Sp1, but not AP-1, were upregulated (Supplementary Figure S6) . To examine whether JWA regulates integrin a V and b 3 promoter transcriptional activities through Ets-1 or Sp1, Ets-1 and Sp1 siRNA were transfected into B16-As and A375-sh cells, respectively. Western blot result showed that integrin a V and b 3 protein expression could be efficiently silenced by Sp1 siRNA more than Ets-1 siRNA (Figure 5a ). Consistently, after SP1 siRNA knockdown in B16-As and A375-sh cells, the ability of cell adhesion and invasion was significantly decreased (Figures 5b-e) . These data provide further evidence that JWA may regulate a V b 3 transcription via Sp1 transcription factor.
JWA expression is decreased in malignant melanoma
We further examined JWA, a V and b 3 protein expression in human tissues. The study included 13 normal nevi, 5 dysplastic nevi and 13 malignant melanomas treated at the Surgery Branch of the Nantong Tumor Hospital from 2006 to 2008. There were 14 men and 17 women. Their average age was 59.71 ± 19.19 years (median, 65 range, 15-84).
The expression levels of JWA and integrin a V and b 3 were determined by immunohistochemistry using specific antibodies. Various expression levels of these proteins were observed in normal nevi, dysplastic nevi and malignant melanoma biopsies (Figure 6a ). The JWA protein seems to be predominantly localized in the cytoplasm or the membrane of the cells. The high level of immunoreactivity for JWA was detected in normal nevi. In contrast, very weak immunoreactivity of JWA was observed in dysplastic nevi and malignant melanoma. JWA staining had a significant inverse correlation with integrin a V and b 3 expression in these biopsies ( Figure 6b ). As the expression of JWA protein is reduced in advanced melanomas, we examined JWA protein level in normal human epithelial melanocytes, B16 and A375 cell lines. Western blot results showed that JWA is reduced in melanoma cell lines compared with normal melanocytes (Figure 6c ). 
Discussion
JWA was initially isolated as a retinotic acid responsive and cytosleleton-associated gene (Zhou et al., 1999) . Previously, we identified JWA as a novel mitogenactivated protein, which binds to a-and b-tubulin and probably has an important role in the regulation of microtubule stability (Cao et al., 2002) . Our recent data showed that JWA was essential for the rearrangement of F-actin cytoskeleton and activation of MAPK cascades induced by As 2 O 3 and PMA. JWA deficiency blocked the inhibitory effect of As 2 O 3 on HeLa cell migration, but enhanced cell migration after PMA treatment (Chen et al., 2007a) . As increased cell migration is a crucial step in cancer metastasis, these findings implied that JWA may regulate the metastatic potential of cancer cells.
In this study we demonstrated that downregulation of JWA accelerates melanoma cell migration and adhesion, and promotes cell invasion through matrigel-coated chamber in vitro. As JWA regulates these key processes involved in melanoma progression, we asked whether JWA would affect overall tumor metastasis in vivo. Strikingly, loss of JWA significantly enhanced melanoma lung metastasis in an in vivo model. These findings indicate that JWA is a potential tumor suppressor, consistent with previous reports showing that JWA protect cells from reactive oxygen species-induced DNA damage and promote As 2 O 3 triggered cancer cell apoptosis (Chen et al., 2007b; Zhou et al., 2008; Wang et al., 2009) .
We found that JWA inhibits melanoma metastasis by suppressing integrin a V b 3 signaling. This connection was evidenced by either stable or transient transfection of melanoma cells. When JWA is knocked down, both the mRNA and protein levels of integrin a V b 3 are increased (Figures 3a and b) . Furthermore, inhibitions of integrin Figure 5 JWA regulates melanoma cell adhesion and invasion by Sp1. (a) integrin a V and b3 expression was inhibited by Sp1 siRNA treatment in JWA knockdown cells. Seventy-two hours after transfection with 10 nM of Ets-1 or Sp1 siRNA, total proteins were extracted to detect a V and b 3 expression and nuclear proteins were extracted to detect Ets-1 and Sp1 expression. b-actin was used for the total protein loading control, whereas histone H1 was used for the nuclear protein loading control. (b-e) Cell attachment assay (b, c) and invasion assay (d, e) were carried out after JWA knockdown cells were treated with 10 nM of Ets-1 or Sp1 siRNA. Data were presented as means ± s.d. from three independent experiments. **Po0.01.
a V b 3 function in B16-As and A375-sh cells by siRNA or LM609 strongly reduced the JWA-mediated adhesion and invasion abilities in melanoma cells (Figures 4b-e) . Integrin a V b 3 activates FAK and causes the phosphorylation on Tyr397 site (Mitra and Schlaepfer, 2006; van Nimwegen and van de Water, 2007) . The phosphorylation of FAK on Tyr397 site results in the activation of Rac. Rac then leads to the activation of PAK, which enhances actin polymerization (Zhou and Kramer, 2005; Cheng et al., 2009) . Analysis of the integrin a V b 3 promoter revealed many Sp1 binding sites that are important for integrin a V b 3 transcription in B16 and A375 cells. It was reported that Sp1 could regulate the transcriptional activity of integrin a V b 3 (Tajima et al., 2000; Pechkovsky et al., 2008) . We also confirmed in our study that knocking down Sp1 in B16-As and A375-sh cells by using siRNA reduced the expression of integrin a V b 3 , as well as the adhesion and invasion abilities of melanoma cells (Figures 5a-e) .
Many studies have revealed that integrin a V b 3 has an important role in tumor progression. The integrin a V b 3 is upregulated in glioblastomas and melanomas (Albelda et al., 1990) . Integrin a V b 3 is functionally involved in the malignant spread of various tumor cell types, such as breast carcinoma, prostate carcinoma and melanoma, and supports tumor cell adhesion and invasion through endothelium and matrix protein (Voura et al., 2001; Cooper et al., 2002; Felding-Habermann, 2003) . In melanoma, integrin a V b 3 facilitates the cell adhesion to the extracellular matrix, and therefore facilitates penetration of the basement membrane and invasion into the underlying stroma (Hsu et al., 1998; Li et al., 2001) .
We found that JWA is crucial for melanoma cells to attach to fibronectin and vitronectin-coated plates (Figure 2a ). Fibronectin and vitronectin are two major components in extracellular matrix that cells bind through extracellular domain of integrin a V b 3 (Gladson and Cheresh, 1991) . The key recognition motif is the amino acid triplet Arg-Gly-Asp (RGD) (Sinanan et al., 2008) . In our study we used a V b 3 siRNA and LM609 to knockdown a V b 3 or block a V b 3 binding to RGD in JWA knockdown cells. We found that the adhesion ability of JWA knockdown cells was drastically decreased. This implies that JWA has a central role in transducing signals when melanoma cells engage with extracellular matrix regulating cell attachment by integrin a V b 3 signaling.
We further demonstrated that JWA has a key role in melanoma invasion by regulating MMP-2 expression (Figure 2d ). It was reported that the special role of integrin a V b 3 in tumor invasion and metastasis seems to arise from its ability to recruit and activate MMP-2, which degrades components of the basement membrane and interstitial matrix. The activation of MMP-2 involves the following steps. When MMP-2 binds to its inhibitor TIMP-2, the transmembrane metalloproteinase MT1-MMP recruits the MMP-2-TIMP-2 complex to the cell surface and cleaves the pro-domain of MMP-2 (Sternlicht and Werb, 2001 ). The partially active MMP-2 then interacts with integrin a V b 3 at the leading edge of the cell and becomes fully active (Brooks et al., 1996) . Our results indicated that MMP2 activity increased by 4.5-fold in JWA knockdown cells, thus implying that JWA knockdown increased invasiveness of melanoma cells at least partially by regulating MMP-2 activity.
In summary, we demonstrate that knockdown JWA promotes adhesion and invasion of melanoma cells in vitro and lung metastasis in vivo by regulating transcription factor Sp1 and integrin a V b 3 signaling. Our data revealed a novel pathway for the regulation of integrin a V b 3 signaling that is involved in melanoma metastasis. JWA may serve as a potential prognostic marker and a therapeutic target for human melanoma. 
Materials and methods
Animals and cell lines
Female C57BL/6 mice, 8-10-weeks old, and BALB/c nude mice, 6-weeks old, were obtained from NLARSH China (Shanghai, China) for studies approved by the Animal Care Committee of Nanjing Medical University. C57BL/6 background melanoma B16-F10 cell line and human melanoma cell line A375 were purchased from the Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences (Shanghai, China). Melanocytes were a gift from Dr Le Poole (Loyola University Chicago Oncology Institute, Maywood, IL, USA). Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin and 10% fetal bovine serum. The cells were grown at 37 1C in the presence of 5% CO 2 in a humidified incubator.
Plasmids and transfections
The pEGFP-C1-antisense JWA and pEGFP-C1-JWA expression plasmids were described previously (Chen et al., 2007a (Chen et al., , 2007b . The JWA siRNA expression cassette and scrambled shRNA (Huang et al., 2006) were subcloned into the linearized vector pSEC (Ambion, Austin, TX, USA) to produce JWA shRNA and control shRNA plasmids, respectively. The identity of the plasmids was confirmed by sequencing.
Transfection of the pEGFP-C1-antisense JWA plasmid and the pEGFP-C1 vector DNA into the B16-F10 and A375 cells were carried out using Lipofectamine 2000 transfection reagent (Invitrogen, Shanghai, China) following the manufacturer's protocol. G418 (50 mg/ml) was added to each dish at a final concentration of 800 mg/ml for B16-F10 and A375, until only positive cells remained. The JWA expression in G418-selected B16-F10 and A375 cells were verified by western blotting and these stable clones were found to possess either stable knockdown of JWA expression (B16-As and A375-As) or vector control B16 (B16-Vec and A375-Vec), respectively. For transient transfection, A375 cells were transfected with JWA shRNA to knockdown JWA expression. The transient transfection efficiency is over 70% for A375 cell line. B16-As cells were transfected with pEGFP-C1-JWA expression plasmids to enhance JWA expression.
Tail vein metastasis assay
To produce experimental metastasis, the C57BL/6 mice were randomly divided into two groups consisting of 12 mice each. JWA knockdown and vector control B16-F10 cells were suspended in PBS. The mice were injected intravenously with 1 Â 10 5 B16 cells in 0.2 ml of PBS through tail vein. After 21 days, six mice in each group were killed, and their lungs were resected and photos were taken before fixation in 10% buffered formalin. The other six lungs of each group were put into liquid nitrogen for further molecular pathway analysis. The number of metastatic nodules presented on the surface of each set of lungs was counted by visual inspection using a stereoscopic dissecting microscope.
The BALB/c nude mice were randomly divided into two groups consisting of 10 mice each. JWA knockdown and vector control A375 cells were suspended in PBS. The mice were injected intravenously with 1.75 Â 10 6 A375 cells in 0.2 ml of PBS through tail vein. After 30 days, the two groups of mice were killed, the subcutaneous metastatic nodules and four organs of abundant blood supply (lungs, liver, kidneys and brain) were taken for fixation in 10% buffered formalin and further histopathological analysis.
Adhesion assay 96-well plates were coated with 1.25 mg/ml fibronectin or vitronectin (Sigma, St Louis, MO, USA) in 100 ml PBS overnight at 4 1C. Wells coated with BSA served as negative control. The plates were blocked with 2.5 mg/ml BSA for 2 h in DMEM at 37 1C. Cells were trypsinized and 2 Â 10 4 cells were seeded in each well for 1 h at 37 1C. Unattached cells were discarded and the attached cells were washed gently with PBS for three times. Cell number was determined by MTT assay.
Invasion assay
The invasion assay was carried out using a modified twochamber plate with a pore size of 8mm. The transwell filter inserts were coated with matrigel. 1 Â 10 5 cells were seeded in serum-free medium in the upper chamber. After 24 h incubation at 37 1C, cells in the upper chamber were carefully removed with a cotton swab and the cells that had traversed the membrane were fixed in methanol, stained with Giemsa, and counted. Zymography 2.5 Â 10 6 cells were seeded in 100-mm plate for 24 h. The proteins in the conditioned medium were concentrated with YM-30 centricon membrane (Millipore, Billerica, MA, USA) at 5000 g for 4 h at 41C. Twenty-five mg of the proteins were loaded in non-redenaturing conditions on a 10% polyacrylamide gel containing 0.1% gelatin (Sigma). After electrophoresis, gel was incubated in Triton X-100 exchange buffer (20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 5 mM CaCl and 2.5% Triton X-100) for 30 min followed by 10 min wash with incubation buffer (same buffer without Triton X-100) for three times. Gel was incubated in incubation buffer overnight at 37 1C, stained with 0.5% Coomassie blue R250 (Sigma) for 1 h and destained with 30% methanol and 10% glacial acetic acid for 1 h. Gelatinolytic activity was shown as clear areas in the gel.
RNA extraction and RT-PCR analysis
Total RNA was extracted from the cells using the Trizol reagent (Gibco BRL, Gaithersburg, MD, USA). Approximately 1 mg of RNA was used for the reverse transcription reaction with OligodT (18 T) (Invitrogen). The cDNA was amplified with the following primers: 5 0 -GCCGGTGCTGAG TATGTC-3 0 (forward) and 5 
RNA interference
Cells (1 Â 10 6 ) were seeded onto 100-mm plates and each well was transfected with 60 ml of 10 mM integrin a V siRNA, integrin b 3 siRNA, Ets-1 siRNA, Sp1 siRNA or control siRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA), using Lipofectamine 2000 transfection reagent (Invitrogen). Seventy-two hours after transfection, cells were washed once with PBS and harvested. Subcellular fractionation and western blotting analysis Nuclear extracts were obtained using the NE-PER Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology, Rockford, IL, USA). Total cell lysates were prepared with a detergent lysis buffer (50 mM Tris, pH 7.4; 150 mM NaCl; 1% NP-40; 0.5% sodium deoxycholate; 0.1% SDS; and the protease inhibitor, 1 mM PMSF). Western blots were carried out as previously described (Cao et al., 2002) . For each treatment group, three parallel samples were applied and equal amounts of proteins from the parallel samples were mixed and used for blots.
The antibodies used were the anti-integrin a V (1:1000), antiintegrin b 3 (1:1000), anti-PAK1 (1:1000), anti-phospho-PAK1 (Ser199/204)/PAK2 (Ser192/197) (1:1000) (Cell Signaling, Beverly, MA, USA); monoclonal anti-FAK (1:1000), antiphospho-FAK (Thr397), monoclonal anti-GFP (1:1000) (BD Transduction Laboratories, San Diego, CA, USA); anti-Ets-1 (1:500), anti-Sp1 (1:500), anti-histone H1 (1:500) (Santa Cruz); goat anti-JWA (1:1000) (Imgenex, San Diego, CA, USA) and anti-b-actin (1:1000) (Boster Biotechnology, Wuhan, China). Anti-integrin a V b 3 functional blocking antibodies (LM609) were purchased from Chemicon International (Temecula, CA, USA). Each blot was repeated three times.
Human specimens and immunohistochemistry
Human samples were obtained, from patients treated at the Surgery Branch of the Nantong Tumor Hospital. Immunohistochemistry was performed according to the avidin biotinalated-HRP complex (ABC) method using a standard ABC kit (Zhongshan biotech, Beijing, China). Series of paraffin imbedding sections of specimens were incubated with polyclonal goat anti-GTRAP3-18/JWA antibody (1:100) (Imgenex, San Diego, CA, USA), anti-integrin a V antibody (1:250) and anti-integrin b 3 antibody (1:50) (Bioworlde Technology, Nanjing, China) overnight at 4 1C, and diaminobenzidine (DAB; Zhongshan Biotech, Beijing, China) was used to produce a brown precipitate. The immunoreactivity was assessed by light microscopy (Olympus BX-51 light microscope) and the image was collected by Camedia Master C-3040 digital camera. The staining was evaluated by immunoreactive score (IRS) (Remmele and Stegner, 1987) , which is calculated by multiplying the scores of staining intensify and the percentage of positive cells. Based on IRS, staining pattern was defined as low expression (IRS: 0-4) and high expression (IRS: 6-12).
Statistical analysis
Data are expressed as the means±s.d. Two-factor analysis of variance procedures and the Dunnett's t-test were used to assess differences within treatment groups. For analysis of immunohistochemical categorical data and the correlation between the levels of JWA and integrin a V b 3 , the Two-tailed Fisher's exact test was used. Differences were considered significant when Po0.05.
